Assessment of new-generation high-power electronic nicotine delivery system as thermal aerosol generation device for inhaled bronchodilators

International Journal of Pharmaceutics

Volumn 518, Issue 1-2, 2017, Pages 264-269

  Pourchez, Jérémie ^a,b,c   de Oliveira, Fabien ^a,b,c,d   Perinel Ragey, Sophie ^b,c,d   Basset, Thierry ^b,c,d   Vergnon, Jean Michel ^b,c,d   Prévôt, Nathalie ^a,b,c,d  

^a ECOLE DES MINES DE SAINT ETIENNE   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LYON   (France)

^d UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Aerosol; Bronchodilator; Electronic cigarette; ENDS; Thermal aerosol generation

Indexed keywords

BRONCHODILATING AGENT; NICOTINE; TERBUTALINE SULFATE; AEROSOL; TERBUTALINE;

AEROSOL; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; HUMAN; LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ELECTRONIC CIGARETTE; HEAT; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; AEROSOLS; BRONCHODILATOR AGENTS; DRUG DELIVERY SYSTEMS; ELECTRONIC CIGARETTES; HOT TEMPERATURE; NICOTINE; PARTICLE SIZE; TERBUTALINE;

EID: 85008512289     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.01.009     Document Type: Article

References (26)

1. Abdelrahim, M.E., Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions. Respir. Med. 104 (2010), 682–689.
2. Albuquerque-Silva, I., Vecellio, L., Durand, M., Avet, J., Le Pennec, D., de Monte, M., Montharu, J., Diot, P., Cottier, M., Dubois, F., Pourchez, J., Particle deposition in a child respiratory tract model: in vivo regional deposition of fine and ultrafine aerosols in baboons. PLoS One, 9, 2014, e95456.
3. Benowitz, N.L., Burbank, A.D., Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc. Med. 26 (2016), 515–523.
4. Bhatnagar, A., Cardiovascular perspective of the promises and perils of E-cigarettes. Circ. Res. 118 (2016), 1872–1875.
5. Callahan-Lyon, P., Electronic cigarettes: human health effects. Tob. Control 23 (2014), ii36–ii40.
6. Dolovich, M.B., Ahrens, R.C., Hess, D.R., Anderson, P., Dhand, R., Rau, J.L., Smaldone, G.C., Guyatt, G., Device selection and outcomes of aerosol therapy: evidence-based guidelines*: American college of chest physicians/American college of asthma, allergy, and immunology. Chest 127 (2005), 335–371.
7. Drummond, M.B., Upson, D., Electronic cigarettes. Potential harms and benefits. Ann. Am. Thorac. Soc. 11 (2014), 236–242.
8. E-cigarettes: an evidence update (2015) − Publications GOV.UK [WWW Document], URL https://www.gov.uk/government/publications/e-cigarettes-an-evidence-update.
9. Fagerstrom, K., Etter, J.-F., Unger, J.B., E-cigarettes: a disruptive technology that revolutionizes our field?. Nicotine Tob. Res. Off. J. Soc. Res. Nicotine Tob. 17 (2015), 125–126.
10. Farsalinos, K.E., Spyrou, A., Tsimopoulou, K., Stefopoulos, C., Romagna, G., Voudris, V., Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci. Rep., 4, 2014, 4133.
11. Farsalinos, K.E., Yannovits, N., Sarri, T., Voudris, V., Poulas, K., Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: regulatory implications. Addiction 111 (2016), 1069–1076.
12. Force C.-C. of the T, Boe, J., Dennis, J.H., O'Driscoll, B.R., Members of Task Force, Bauer, T.T., Carone, M., Dautzenberg, B., Diot, P., Heslop, K., Lannefors, L., European respiratory society guidelines on the use of nebulizers. Eur. Respir. J. 18 (2001), 228–242.
13. Grana, R., Benowitz, N., Glantz, S.A., E-cigarettes: a scientific review. Circulation 129 (2014), 1972–1986.
14. Ibrahim, M., Verma, R., Garcia-Contreras, L., Inhalation drug delivery devices: technology update. Med. Devices Auckl. N. Z. 8 (2015), 131–139.
15. Leclerc, L., Pourchez, J., Aubert, G., Leguellec, S., Vecellio, L., Cottier, M., Durand, M., Impact of airborne particle size, acoustic airflow and breathing pattern on delivery of nebulized antibiotic into the maxillary sinuses using a realistic human nasal replica. Pharm. Res. 31 (2014), 2335–2343.
16. Niven, R., Lynch, M., Moutvic, R., Gibbs, S., Briscoe, C., Raff, H., Safety and toxicology of cyclosporine in propylene glycol after 9-month aerosol exposure to beagle dogs. J. Aerosol Med. Pulm. Drug Deliv. 24 (2011), 205–212.
17. Perinel, S., Leclerc, L., Prévôt, N., Deville, A., Cottier, M., Durand, M., Vergnon, J.-M., Pourchez, J., Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model. Respir. Res., 17, 2016, 78.
18. Pourchez, J., Parisse, S., Sarry, G., Perinel-Ragey, S., Vergnon, J.-M., Clotagatide, A., Prévôt, N., Impact of power level and refill liquid composition on the aerosol output and particle size distribution generated by recent high-power e-cigarette device. J. Aerosol Med. Pulm. Drug Deliv., 2016 Submitted.
19. Prévôt, N., de Oliveira, F., Wintzer, L., Perinel-Ragey, S., Basset, T., Vergnon, J.-M., Pourchez, J., Nicotine delivery from the refill liquid to the aerosol via high-power e-cigarette device. J. Aerosol Med. Pulm. Drug Deliv., 2016 Submitted.
20. Rabinowitz, J.D., Wensley, M., Lloyd, P., Myers, D., Shen, W., Lu, A., Hodges, C., Hale, R., Mufson, D., Zaffaroni, A., Fast onset medications through thermally generated aerosols. J. Pharmacol. Exp. Ther. 309 (2004), 769–775.
21. Rabinowitz, J.D., Lloyd, P.M., Munzar, P., Myers, D.J., Cross, S., Damani, R., Quintana, R., Spyker, D.A., Soni, P., Cassella, J.V., Ultra-fast absorption of amorphous pure drug aerosols via deep lung inhalation. J. Pharm. Sci. 95 (2006), 2438–2451.
22. Schraufnagel, D.E., Blasi, F., Drummond, M.B., Lam, D.C.L., Latif, E., Rosen, M.J., Sansores, R., Van Zyl-Smit, R., Forum of International Resiratory Societies Electronic cigarettes. A position statement of the forum of international respiratory societies. Am. J. Respir. Crit. Care Med. 190 (2014), 611–618.
23. Sims, M.W., Aerosol therapy for obstructive lung diseases: device selection and practice management issues. Chest 140 (2011), 781–788.
24. Varlet, V., Farsalinos, K., Augsburger, M., Thomas, A., Etter, J.-F., Toxicity assessment of refill liquids for electronic cigarettes. Int. J. Environ. Res. Public Health 12 (2015), 4796–4815.
25. Wang, T., Noonberg, S., Steigerwalt, R., Lynch, M., Kovelesky, R.A., Rodríguez, C.A., Sprugel, K., Turner, N., Preclinical safety evaluation of inhaled cyclosporine in propylene glycol. J. Aerosol Med. Off J. Int. Soc. Aerosols Med. 20 (2007), 417–428.
26. Williams, M., Villarreal, A., Bozhilov, K., Lin, S., Talbot, P., Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One, 8, 2013, e57987.